Roivant Sciences
ROIV
ROIV
314 hedge funds and large institutions have $6.65B invested in Roivant Sciences in 2024 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 93 increasing their positions, 102 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
314
Holders Change
+24
Holders Change %
+8.28%
% of All Funds
4.18%
Holding in Top 10
17
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.23%
New
67
Increased
93
Reduced
102
Closed
40
Calls
$9.58M
Puts
$11.1M
Net Calls
-$1.53M
Net Calls Change
+$14.2M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$409M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$62.6M |
| 3 |
3
Invesco
Atlanta,
Georgia
|
$113M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$522M |
| 5 |
TCIM
5
TOMS Capital Investment Management
New York
|
$69.6M |
